6618 — JD Health International Balance Sheet
0.000.00%
- HK$194.49bn
- HK$141.18bn
- CNY58.16bn
- 91
- 26
- 100
- 87
Annual balance sheet for JD Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 40,303 | 41,990 | 47,672 | 41,221 | 51,236 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 538 | 451 | 1,976 | 956 | 813 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 42,705 | 45,705 | 56,447 | 47,850 | 58,460 |
| Net Property, Plant And Equipment | 115 | 711 | 705 | 741 | 803 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 43,995 | 48,002 | 61,277 | 64,288 | 71,275 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,682 | 8,005 | 16,356 | 14,585 | 15,521 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 4,744 | 8,149 | 16,497 | 14,933 | 16,044 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 39,251 | 39,853 | 44,780 | 49,356 | 55,231 |
| Total Liabilities & Shareholders' Equity | 43,995 | 48,002 | 61,277 | 64,288 | 71,275 |
| Total Common Shares Outstanding |